With the EMA’s guidance on the use of real world evidence in its regulatory decision-making, and federated learning networks that continue to support pharma, the integration of real world evidence into clinical research is transforming drug development.

Following on from the 11th IMPACCT Real World Evidence Summit US, created-by biopharma-for biopharma, the IMPACCT Real World Evidence Summit Europe 2024 stood out as the only European industry-led meeting dedicated to the practical applications of real world evidence across all stages of clinical research from patient identification through to phase IV that would have empowered you to revolutionise your clinical research capabilities.

Taking place in Amsterdam in February 2024, the summit gathered biopharma for an unparalleled learning and networking opportunity, enabling them  to bridge the evidence gap between clinical research and practice in a time-efficient and cost-effective way.